International Prospective Registry of Disseminated Intravascular Coagulation

NCT03577015 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-08-13

No results posted yet for this study

Summary

Objectives: to evaluate the current diagnostic and therapeutic approaches for sepis-associated disseminated intravascular coagulation (DIC) in a large prospective registry.

Design: prospective, multicenter, international registry. Study population: patients 18 years or older with severe infection to be potentially associated with DIC will be eligible for the study. The clinical visits and monitoring of the patients will follow local routine practices. No specific imaging tests or laboratory evaluations will be required and patients will be evaluated and treated according to local policy. All the involved centers will be asked to update information on included patients at 2, 4, 6, 8, 10 and 28 days after severe infection diagnosis.

Study outcomes: The primary outcome of the study is the development of DIC. Secondary outcomes are thrombotic (arterial and venous) and bleeding events, overall mortality at 28 days.

Study sample, feasibility, and analysis plan: We plan to enroll a minimum of 1000 patients.

Conditions

  • Disseminated Intravascular Coagulation

Sponsors & Collaborators

  • Università degli Studi dell'Insubria

    collaborator OTHER
  • University of Chieti

    collaborator OTHER
  • Ospedale S. Antonio

    collaborator UNKNOWN
  • Poliambulanza Foundation Hospital

    collaborator UNKNOWN
  • Manchester Royal Infirmary

    collaborator UNKNOWN
  • Juntendo University

    collaborator OTHER
  • Marcella Muller

    lead OTHER

Principal Investigators

  • Sabrina Boraso, MD · OSPEDALE S. ANTONIO, Padova, Italy

  • Marcello Di Nisio, MD PhD · University of Chieti, Italy

  • Jecko Tachil, MD PhD · Manchester Royal Infirmary, Manchester, England

  • Pierluigi Ferretti, MD · Fondazione Poliambulanza, Brescia, Italy

  • Toshiaki Iba, MD PhD · (Juntendo University, Department of Emergency and Disaster Medicine, Tokyo, Japan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2021-04-01
Completion
2021-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03577015 on ClinicalTrials.gov